Form 4 for RGEN REPLIGEN CORP
Accepted 2022-10-11 00:00:00 ET · period of report 2022-10-07 · accession 0000899243-22-033400 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-10-11 | 2022-10-07 | RGEN | Snodgres Jon | CFO | M - OptEx | $59.52 | +466 | 35.0K | +1% | +$27.7K |
| D | 2022-10-11 | 2022-10-07 | RGEN | Snodgres Jon | CFO | M - OptEx | $0.00 | +466 | 2,108 | +28% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-07 | M | A | 466 | $59.52 | 34,972 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-10-07 | M | A | 466 | $0.00 | 2,108 | D | $59.52 · — to 2029-02-28 | 466 Common Stock | (F2) This option is fully vested and exercisable. |